Ardent Health Q2 Net Income Attributable to Company $16.9M, down from $73.0M
Ardent Health, Inc. reported a significant decline in net income attributable to the company for the second quarter and first half of 2026. For the three months ended June 30, 2026, net income attributable to Ardent Health, Inc. fell to $16.9 million from $73.0 million in the prior year, with basic EPS decreasing to $0.12 from $0.52. Total revenue for the quarter also saw a slight decrease to $1.62 billion. For the six months, net income attributable to the company was $56.7 million, down from $114.3 million, despite a slight increase in total revenue to $3.22 billion. The company's operating expenses rose, partly due to non-recurring severance costs and CEO transition expenses.
Key Highlights
- Q2 2026 net income attributable to Ardent Health, Inc. fell to $16.9M from $73.0M YoY.
- Q2 2026 basic EPS decreased to $0.12 from $0.52 in the prior year.
- Total revenue for Q2 2026 slightly decreased to $1.62B from $1.65B YoY.
- Six-month 2026 net income attributable to Ardent Health, Inc. was $56.7M, down from $114.3M YoY.
- Six-month 2026 total revenue increased to $3.22B from $3.14B YoY.
- General and administrative costs rose to $61.2M in Q2 2026 from $32.6M YoY.
- Net cash provided by operating activities increased to $136.5M for six months 2026.
- Company repurchased $13.0M of common stock in six months 2026.
Price Impact
More from ARDT
Ardent Health Recharacterizes CEO Departure as 'Cause', Halts $4.5M Severance
Ardent Health Q2 Net Income $17M; Adjusted EBITDA $115M; Reaffirms FY26 Guidance
Ardent Health Finalizes Separation Agreement with Former CEO Martin Bonick